Literature DB >> 23625928

JosD1, a membrane-targeted deubiquitinating enzyme, is activated by ubiquitination and regulates membrane dynamics, cell motility, and endocytosis.

Takahiro Seki1, Lijie Gong, Aislinn J Williams, Norio Sakai, Sokol V Todi, Henry L Paulson.   

Abstract

The functional diversity of deubiquitinating enzymes (DUBs) is not well understood. The MJD family of DUBs consists of four cysteine proteases that share a catalytic "Josephin" domain. The family is named after the DUB ATXN3, which causes the neurodegenerative disease Machado-Joseph disease. The two closely related Josephin domain-containing (JosD) proteins 1 and 2 consist of little more than the Josephin domain. To gain insight into the properties of Josephin domains, we investigated JosD1 and JosD2. JosD1 and JosD2 were found to differ fundamentally in many respects. In vitro, only JosD2 can cleave ubiquitin chains. In contrast, JosD1 cleaves ubiquitin chains only after it is monoubiquitinated, a form of posttranslational-dependent regulation shared with ATXN3. A significant fraction of JosD1 is monoubiquitinated in diverse mouse tissues. In cell-based studies, JosD2 localizes to the cytoplasm whereas JosD1 preferentially localizes to the plasma membrane, particularly when ubiquitinated. The membrane occupancy by JosD1 suggests that it could participate in membrane-dependent events such as cell motility and endocytosis. Indeed, time-lapse imaging revealed that JosD1 enhances membrane dynamics and cell motility. JosD1 also influences endocytosis in cultured cells by increasing the uptake of endocytic markers of macropinocytosis while decreasing those for clathrin- and caveolae-mediated endocytosis. Our results establish that two closely related DUBs differ markedly in activity and function and that JosD1, a membrane-associated DUB whose activity is regulated by ubiquitination, helps regulate membrane dynamics, cell motility, and endocytosis.

Entities:  

Keywords:  Ataxin-3; Cell Motility; Deubiquitinating Enzyme; Deubiquitination; Endocytosis; Josephin Domain-containing Protein 1; Membrane Dynamics; Ubiquitin; Ubiquitination

Mesh:

Substances:

Year:  2013        PMID: 23625928      PMCID: PMC3682520          DOI: 10.1074/jbc.M113.463406

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  33 in total

Review 1.  Breaking the chains: structure and function of the deubiquitinases.

Authors:  David Komander; Michael J Clague; Sylvie Urbé
Journal:  Nat Rev Mol Cell Biol       Date:  2009-08       Impact factor: 94.444

Review 2.  Macropinocytosis: an endocytic pathway for internalising large gulps.

Authors:  Jet Phey Lim; Paul A Gleeson
Journal:  Immunol Cell Biol       Date:  2011-03-22       Impact factor: 5.126

Review 3.  Ubiquitin-specific proteases as cancer drug targets.

Authors:  Wolfgang Sippl; Vincent Collura; Frédéric Colland
Journal:  Future Oncol       Date:  2011-05       Impact factor: 3.404

4.  Ube2w and ataxin-3 coordinately regulate the ubiquitin ligase CHIP.

Authors:  K Matthew Scaglione; Eszter Zavodszky; Sokol V Todi; Srikanth Patury; Ping Xu; Edgardo Rodríguez-Lebrón; Svetlana Fischer; John Konen; Ana Djarmati; Junmin Peng; Jason E Gestwicki; Henry L Paulson
Journal:  Mol Cell       Date:  2011-08-19       Impact factor: 17.970

5.  Crystal structure of a Josephin-ubiquitin complex: evolutionary restraints on ataxin-3 deubiquitinating activity.

Authors:  Stephen D Weeks; Kimberly C Grasty; Lisa Hernandez-Cuebas; Patrick J Loll
Journal:  J Biol Chem       Date:  2010-11-30       Impact factor: 5.157

6.  Negative guidance factor-induced macropinocytosis in the growth cone plays a critical role in repulsive axon turning.

Authors:  Adrianne L Kolpak; Jun Jiang; Daorong Guo; Clive Standley; Karl Bellve; Kevin Fogarty; Zheng-Zheng Bao
Journal:  J Neurosci       Date:  2009-08-26       Impact factor: 6.167

7.  Ubiquitination directly enhances activity of the deubiquitinating enzyme ataxin-3.

Authors:  Sokol V Todi; Brett J Winborn; K Matthew Scaglione; Jessica R Blount; Sue M Travis; Henry L Paulson
Journal:  EMBO J       Date:  2009-01-15       Impact factor: 11.598

8.  The Machado-Joseph disease-associated mutant form of ataxin-3 regulates parkin ubiquitination and stability.

Authors:  Thomas M Durcan; Maria Kontogiannea; Thorhildur Thorarinsdottir; Lara Fallon; Aislinn J Williams; Ana Djarmati; Tadeu Fantaneanu; Henry L Paulson; Edward A Fon
Journal:  Hum Mol Genet       Date:  2010-10-11       Impact factor: 6.150

9.  Activity and cellular functions of the deubiquitinating enzyme and polyglutamine disease protein ataxin-3 are regulated by ubiquitination at lysine 117.

Authors:  Sokol V Todi; K Matthew Scaglione; Jessica R Blount; Venkatesha Basrur; Kevin P Conlon; Annalisa Pastore; Kojo Elenitoba-Johnson; Henry L Paulson
Journal:  J Biol Chem       Date:  2010-10-13       Impact factor: 5.157

10.  The UBA-UIM domains of the USP25 regulate the enzyme ubiquitination state and modulate substrate recognition.

Authors:  Amanda Denuc; Anna Bosch-Comas; Roser Gonzàlez-Duarte; Gemma Marfany
Journal:  PLoS One       Date:  2009-05-15       Impact factor: 3.240

View more
  30 in total

1.  The de-ubiquitinating enzyme ataxin-3 does not modulate disease progression in a knock-in mouse model of Huntington disease.

Authors:  Li Zeng; Sara J Tallaksen-Greene; Bo Wang; Roger L Albin; Henry L Paulson
Journal:  J Huntingtons Dis       Date:  2013

2.  MJD and OTU deubiquitinating enzymes in Schistosoma mansoni.

Authors:  Roberta Verciano Pereira; Matheus de Souza Gomes; Marcela Pereira Costa; Liana Konovaloff Jannotti Passos; William de Castro Borges; Renata Guerra-Sá
Journal:  Parasitol Res       Date:  2015-05-01       Impact factor: 2.289

3.  Duck Tembusu Virus Inhibits Type I Interferon Production through the JOSD1-SOCS1-IRF7 Negative-Feedback Regulation Pathway.

Authors:  Shanzhi Huang; Juan Huang; Min Cui; Xuedong Wu; Mingshu Wang; Dekang Zhu; Shun Chen; Mafeng Liu; Xinxin Zhao; Ying Wu; Qiao Yang; Shaqiu Zhang; Xumin Ou; Sai Mao; Qun Gao; Yanling Yu; Bin Tian; Yunya Liu; Ling Zhang; Zhongqiong Yin; Bo Jing; Xiaoyue Chen; Anchun Cheng; Renyong Jia
Journal:  J Virol       Date:  2022-09-07       Impact factor: 6.549

4.  Ubiquitination regulates the neuroprotective function of the deubiquitinase ataxin-3 in vivo.

Authors:  Wei-Ling Tsou; Aaron A Burr; Michelle Ouyang; Jessica R Blount; K Matthew Scaglione; Sokol V Todi
Journal:  J Biol Chem       Date:  2013-10-08       Impact factor: 5.157

5.  JOSD1 inhibits mitochondrial apoptotic signalling to drive acquired chemoresistance in gynaecological cancer by stabilizing MCL1.

Authors:  Xiaowei Wu; Qingyu Luo; Pengfei Zhao; Wan Chang; Yating Wang; Tong Shu; Fang Ding; Bin Li; Zhihua Liu
Journal:  Cell Death Differ       Date:  2019-05-01       Impact factor: 15.828

6.  Development and validation of a transcriptomic signature-based model as the predictive, preventive, and personalized medical strategy for preterm birth within 7 days in threatened preterm labor women.

Authors:  Yuxin Ran; Jie He; Wei Peng; Zheng Liu; Youwen Mei; Yunqian Zhou; Nanlin Yin; Hongbo Qi
Journal:  EPMA J       Date:  2022-01-18       Impact factor: 6.543

7.  Trinucleotide repeats: a structural perspective.

Authors:  Bruno Almeida; Sara Fernandes; Isabel A Abreu; Sandra Macedo-Ribeiro
Journal:  Front Neurol       Date:  2013-06-20       Impact factor: 4.003

8.  The deubiquitinase JOSD2 is a positive regulator of glucose metabolism.

Authors:  Lyudmila Krassikova; Boxi Zhang; Divya Nagarajan; André Lima Queiroz; Merve Kacal; Evangelos Samakidis; Helin Vakifahmetoglu-Norberg; Erik Norberg
Journal:  Cell Death Differ       Date:  2020-10-20       Impact factor: 15.828

Review 9.  Post-Translational Modifications of Deubiquitinating Enzymes: Expanding the Ubiquitin Code.

Authors:  Yanfeng Wang; Feng Wang
Journal:  Front Pharmacol       Date:  2021-06-10       Impact factor: 5.810

10.  JOSD1 promotes proliferation and chemoresistance of head and neck squamous cell carcinoma under the epigenetic regulation of BRD4.

Authors:  Chao Jing; Dandan Liu; Qingchuan Lai; Linqi Li; Mengqian Zhou; Beibei Ye; Yue Wu; Hong Li; Kai Yue; Yansheng Wu; Yuansheng Duan; Xudong Wang
Journal:  Cancer Cell Int       Date:  2021-07-14       Impact factor: 5.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.